Alpha Cubed Investments’s Novavax NVAX Stock Holding History

Alpha Cubed Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,432	Closed	-$253K	–	337
2022 Q1	$253K	Buy	+3,432	New	+$306K	0.02%	281
2016 Q2	–	Sell	-650	Closed	-$67K	–	162
2016 Q1	$67K	Buy	+650	New	+$69.7K	0.02%	156

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpha Cubed Investments's NVAX Position: Q2 2022 in Review

Alpha Cubed Investments sold out of Novavax (NVAX) in Q2 2022, closing a stake of 3,432 shares — an estimated $253K sold.

Alpha Cubed Investments first reported a position in NVAX in Q1 2016 and held it in 2 quarters. The position peaked at $253K in Q1 2022. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Alpha Cubed Investments reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Alpha Cubed Investments sold 3,432 Novavax shares in Q2 2022, an estimated $253K.
Alpha Cubed Investments first reported a position in Novavax in Q1 2016 and held it in 2 quarters.
Alpha Cubed Investments's Novavax position peaked at $253K in Q1 2022.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Alpha Cubed Investments's 13F filing for Q2 2022, filed 22 Jul 2022.